Avista Public Acquisition Corp. II Human Resources Contracts & Agreements
16 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Change of Control Agreements (3)
- Severance Agreements (2)
- Transition Agreements (4)
- Change in Control Severance Agreement, effective November 1, 2022, between OmniAb, Inc. and Charles S. Berkman (Filed With SEC on March 30, 2023)
- Change in Control Severance Agreement, effective November 1, 2022, between OmniAb, Inc. and Kurt A. Gustafson (Filed With SEC on March 30, 2023)
- Change in Control Severance Agreement, effective November 1, 2022, between OmniAb, Inc. and Matthew W. Foehr (Filed With SEC on March 30, 2023)
- OmniAb, Inc. Severance Plan (Filed With SEC on November 7, 2022)
- Form of Performance Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Restricted Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Stock Option Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by OmniAb, Inc. to Ligand... (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by Ligand Pharmaceuticals... (Filed With SEC on November 7, 2022)
- OmniAb, Inc. Severance Plan (Filed With SEC on November 7, 2022)
- Form of Performance Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Restricted Stock Unit Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Form of Stock Option Agreement under the OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by OmniAb, Inc. to Ligand... (Filed With SEC on November 7, 2022)
- Transition Services Agreement, dated November 1, by and between Ligand Pharmaceuticals Incorporated and OmniAb, Inc., with respect to services provided by Ligand Pharmaceuticals... (Filed With SEC on November 7, 2022)
- OmniAb, Inc. 2022 Incentive Award Plan (Filed With SEC on October 24, 2022)
